- Home
- Publications
- Publication Search
- Publication Details
Title
Achromobacter Infections and Treatment Options
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 11, Pages -
Publisher
American Society for Microbiology
Online
2020-08-17
DOI
10.1128/aac.01025-20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS)
- (2020) T. Garrigos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Expansion and improvement of MALDI-TOF MS databases for accurate identification of Achromobacter species
- (2020) Mariana Papalia et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Chronic Conjunctivitis From a Retained Contact Lens
- (2019) Jawad I. Arshad et al. Eye & Contact Lens-Science and Clinical Practice
- Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137
- (2019) Lucie Amoureux et al. Journal of Cystic Fibrosis
- Evaluation of the immunochromatographic NG-test Carba5 for rapid identification of carbapenemase in non-fermenters
- (2019) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina
- (2019) Mariana Papalia et al. REVISTA ARGENTINA DE MICROBIOLOGIA
- Achromobacter spp. healthcare associated infections in the French West Indies: a longitudinal study from 2006 to 2016
- (2019) Karine Marion-Sanchez et al. BMC INFECTIOUS DISEASES
- In Vitro Activities of β-Lactam–β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens
- (2019) Lindsay J. Caverly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Achromobacter veterisilvae sp. nov., from a mixed hydrogen-oxidizing bacteria enrichment reactor for microbial protein production
- (2019) Charles Dumolin et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- 2275. Novel Therapeutic Options for the Treatment of Multi-Drug-Resistant Achromobacter Respiratory Infections
- (2019) Theora Canonica et al. Open Forum Infectious Diseases
- 730. Cefiderocol for the Treatment of Achromobacter xylosoxidans Infections in Two Lung Transplant Patients with Cystic Fibrosis
- (2019) Nathaniel C Warner et al. Open Forum Infectious Diseases
- Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis
- (2019) Amy Coward et al. Journal of Cystic Fibrosis
- Achromobacter endocarditis in native cardiac valves — an autopsy case report and review of the literature
- (2018) Rong Xia et al. CARDIOVASCULAR PATHOLOGY
- In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis
- (2018) Vincent Mathy et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Phage therapy against Achromobacter xylosoxidan s lung infection in a patient with cystic fibrosis: a case report
- (2018) N. Hoyle et al. RESEARCH IN MICROBIOLOGY
- Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients
- (2018) Eric Farfour et al. Transplant Infectious Disease
- Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans
- (2018) Frank Fleurbaaij et al. Scientific Reports
- IN VITRO ANTIMICROBIAL ACTIVITY OF CEFTOLOZANE/TAZOBACTAM AGAINST P. AERUGINOSA AND OTHER NON-FERMENTING GRAM-NEGATIVE ORGANISMS IN ADULTS WITH CYSTIC FIBROSIS
- (2018) A. Gramegna et al. Journal of Global Antimicrobial Resistance
- Ritkábban előforduló, alsó légúti fertőzést okozó Gram-negatív nem fermentáló pálcák
- (2018) Emese Juhász et al. ORVOSI HETILAP
- In Vitro Activity of Ceftolozane/Tazobactam versus Non-Fermenting, Gram-Negative, Cystic Fibrosis Isolates
- (2018) Jeanne B Forrester et al. Open Forum Infectious Diseases
- Fluoroquinolone-resistant Achromobacter xylosoxidans clinical isolates from Serbia: high prevalence of the aac-(6′)-Ib-cr gene among resistant isolates
- (2018) Branislav Lilić et al. FOLIA MICROBIOLOGICA
- Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients
- (2018) María Díez-Aguilar et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Defining antimicrobial resistance in cystic fibrosis
- (2018) Timothy J. Kidd et al. Journal of Cystic Fibrosis
- Replicon typing of plasmids in environmental Achromobacter sp. producing quinolone-resistant determinants
- (2018) João Pedro Rueda Furlan et al. APMIS
- In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015
- (2018) James A. Karlowsky et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- 1375. In vitro Activity of Cefiderocol and Comparator Agents against Gram-Negative Isolates from Cancer Patients
- (2018) Kenneth V I Rolston et al. Open Forum Infectious Diseases
- A Pan-Genomic Approach to Understand the Basis of Host Adaptation in Achromobacter
- (2017) Julie Jeukens et al. Genome Biology and Evolution
- Prevalence and species distribution of Achromobacter sp. cultured from cystic fibrosis patients attending the Aarhus centre in Denmark
- (2017) Sinne Søberg Gade et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing
- (2017) Chao Liu et al. Journal of Infection in Developing Countries
- Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin
- (2017) Brankica Filipic et al. Frontiers in Cellular and Infection Microbiology
- Achromobacter xylosoxidans is the predominant Achromobacter species isolated from diverse non-respiratory samples
- (2016) L. AMOUREUX et al. EPIDEMIOLOGY AND INFECTION
- Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis
- (2016) R. H. V. PEREIRA et al. EPIDEMIOLOGY AND INFECTION
- Taxonomic dissection of Achromobacter denitrificans Coenye et al. 2003 and proposal of Achromobacter agilis sp. nov., nom. rev., Achromobacter pestifer sp. nov., nom. rev., Achromobacter kerstersii sp. nov. and Achromobacter deleyi sp. nov.
- (2016) Peter A. Vandamme et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates
- (2016) Lucie Amoureux et al. Journal of Cystic Fibrosis
- Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile
- (2016) Agila K. Pragasam et al. Annals of Clinical Microbiology and Antimicrobials
- The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
- (2015) Xian-Zhi Li et al. CLINICAL MICROBIOLOGY REVIEWS
- Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation
- (2015) Leonard Jason Lobo et al. TRANSPLANTATION
- Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients
- (2015) Kate L. Ormerod et al. PeerJ
- Genetic Adaptation of Achromobacter sp. during Persistence in the Lungs of Cystic Fibrosis Patients
- (2015) Winnie Ridderberg et al. PLoS One
- Genomic Insights into Intrinsic and Acquired Drug Resistance Mechanisms in Achromobacter xylosoxidans
- (2014) Yongfei Hu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cystic Fibrosis Pulmonary Guidelines
- (2013) Peter J. Mogayzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Detection of Achromobacter xylosoxidans in Hospital, Domestic, and Outdoor Environmental Samples and Comparison with Human Clinical Isolates
- (2013) Lucie Amoureux et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Comparison of Matrix-Assisted Laser Desorption Ionization–Time of Flight (MALDI-TOF) Mass Spectrometry Platforms for the Identification of Gram-Negative Rods from Patients with Cystic Fibrosis
- (2013) Kevin Alby et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis
- (2013) M. Wang et al. Journal of Cystic Fibrosis
- Skin and soft tissue infection caused by Achromobacter xylosoxidans: report of 14 cases
- (2013) Daniel Tena et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Classification of Achromobacter genogroups 2, 5, 7 and 14 as Achromobacter insuavis sp. nov., Achromobacter aegrifaciens sp. nov., Achromobacter anxifer sp. nov. and Achromobacter dolens sp. nov., respectively
- (2013) Peter Vandamme et al. SYSTEMATIC AND APPLIED MICROBIOLOGY
- Genetic and Biochemical Characterization of a Novel Metallo-β-Lactamase, TMB-1, from an Achromobacter xylosoxidans Strain Isolated in Tripoli, Libya
- (2012) Allaaeddin El Salabi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump
- (2012) Julien Bador et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Achromobacter xylosoxidans: An Emerging Pathogen Carrying Different Elements Involved in Horizontal Genetic Transfer
- (2012) German Matías Traglia et al. CURRENT MICROBIOLOGY
- A Multilocus Sequence Typing Scheme Implies Population Structure and Reveals Several Putative Novel Achromobacter Species
- (2012) T. Spilker et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: First French data
- (2012) Lucie Amoureux et al. Journal of Cystic Fibrosis
- Identification and distribution of Achromobacter species in cystic fibrosis
- (2012) Theodore Spilker et al. Journal of Cystic Fibrosis
- Calcaneal osteomyelitis due to Achromobacter xylosoxidans: a case report
- (2012) Kadri Ozer et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- In Vitro Antimicrobial Activity of “Last-Resort” Antibiotics Against Unusual Nonfermenting Gram-Negative Bacilli Clinical Isolates
- (2012) Herve Jacquier et al. Microbial Drug Resistance
- Successful treatment with doripenem of ventriculitis due to Achromobacter xylosoxidans
- (2012) M. S. Gelfand et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Achromobacter animicus sp. nov., Achromobacter mucicolens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples
- (2012) Peter Vandamme et al. SYSTEMATIC AND APPLIED MICROBIOLOGY
- Comparative Activities of Tigecycline and Other Tetracyclines against Nonfermenting Gram-Negative Bacilli, ExcludingAcinetobacterspp.
- (2011) Marisa N. Almuzara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM
- (2011) Julien Bador et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
- (2011) A. Lambiase et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment
- (2011) Winnie Ridderberg et al. Journal of Cystic Fibrosis
- MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients
- (2011) Ana Fernández-Olmos et al. Journal of Cystic Fibrosis
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods
- (2009) Marisa Almuzara et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Low Rates of Pseudomonas aeruginosa Misidentification in Isolates from Cystic Fibrosis Patients
- (2009) T. J. Kidd et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Characterization of a Naturally Occurring Class D -Lactamase from Achromobacter xylosoxidans
- (2008) Y. Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Achromobacter xylosoxidansrespiratory tract infections in cystic fibrosis patients
- (2008) TIZIANA RASO et al. APMIS
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nonfermenting Gram-Negative Bacilli Isolated from Cystic Fibrosis Patients
- (2008) N. Degand et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Urinary tract infection due toAchromobacter xylosoxidans: Report of 9 cases
- (2008) Daniel Tena et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More